MedTrace Logo

FLT3-ITD Gene Mutation and CD135 Expression in Acute Myeloid Leukemia.

NCT05383014 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 82

Last updated 2022-05-19

No results posted yet for this study

Summary

1. To evaluate expression levels of CD135
2. To assess the frequency of FLT3 gene mutations (ITD)
3. association between FLT3-ITD mutation and CD135 expression and their correlation with hematological, immunophenotypic,and biochemical features.

Conditions

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Marwa Mohammed Thabet, lecturer · clinical pathology department , Assiut University Hospital.

  • Alaa soliman Abd Elkadir, lecturer · clinical pathology department , Assiut University Hospital.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2024-06-01
Completion
2024-07-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05383014 on ClinicalTrials.gov